Early and Sustained Remission after Treatment with Subcutaneously Administered Golimumab Is Associated with Normalized Health-Related Quality of Life in Patients with Moderate to Severe Ulcerative Colitis: Post-hoc Analysis from PURSUIT Induction and Maintenance Trials Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Sandborn, William
  • Colombel, Jean-Frederic
  • Feagan, Brian
  • Marano, Colleen
  • Strauss, Richard
  • Han, Chenglong
  • Gathany, Timothy
  • Johanns, Jewel
  • Zhang, Hongyan
  • Gibson, Peter
  • Collins, Judith
  • Jarnerot, Gunnar
  • Rutgeerts, Paul
  • Reinisch, Walter

publication date

  • October 1, 2013